TY - JOUR
T1 - Comparison of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy
AU - Sakai, Masahiro
AU - Hara, Akihiro
AU - Anjo, Saeko
AU - Nakamura, Mikio
N1 - Funding Information:
The author thanks that the fluoroquinolones were kindly provided by their manufacturers; ciprofloxacin (CPFX) was a gift from Bayer (Japan), levofloxacin(LVFX) was a gift from Daiichi Seiyaku Co. Ltd. (Japan), and lomefloxacin(LFLX) was a gift from Shionogi Co. Ltd.(Japan). This work was supported by Daiichi Seiyaku Co. Ltd.
Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1999/1
Y1 - 1999/1
N2 - The complexation of fluoroquinolone antimicrobials with various metal ions have been studied in aqueous solution (pD 2.5, 37°C) by 1H and 13C-NMR spectroscopy. The compounds examined are levofloxacin, ciprofloxacin and lomefloxacin. In each drug, new signals have appeared by the addition of Al3+, suggesting that the complexes are formed between the drug and Al3+ and that the ligand exchange is slow on the NMR time scale. Solution structure of the major species in the presence of 2.0 mol equiv of Al3+ has been proposed based on the large downfield shifts of some specific protons. Signals of both the coordinated and free drugs have shown slight broadening at 90°C due to the enhanced rate in ligand dissociation process, though the coalescence phenomena are not observed even at this temperature. Thus, the complexes are supposed to be stable at the physiological condition. Titration experiments have revealed that the binding ability of levofloxacin toward Al3+ is much stronger than that of ciprofloxacin and lomefloxacin at pD 2.5. In contrast to the complexation with Al3+, the binding of these drugs with other metal ions such as Ca2+ and Mg2+ is much weaker; NMR signals have shown no appreciable downfield shift by the addition of Ca2+ and Mg2+. Based on these results, it is concluded that the fluoroquinolone antimicrobials examined in the present study at pD 2.5 exist as stable complexes in the presence of Al3+ and the absorptivity of the drugs on oral administration could be affected by Al3+. Copyright (C) 1999 Elsevier Science B.V.
AB - The complexation of fluoroquinolone antimicrobials with various metal ions have been studied in aqueous solution (pD 2.5, 37°C) by 1H and 13C-NMR spectroscopy. The compounds examined are levofloxacin, ciprofloxacin and lomefloxacin. In each drug, new signals have appeared by the addition of Al3+, suggesting that the complexes are formed between the drug and Al3+ and that the ligand exchange is slow on the NMR time scale. Solution structure of the major species in the presence of 2.0 mol equiv of Al3+ has been proposed based on the large downfield shifts of some specific protons. Signals of both the coordinated and free drugs have shown slight broadening at 90°C due to the enhanced rate in ligand dissociation process, though the coalescence phenomena are not observed even at this temperature. Thus, the complexes are supposed to be stable at the physiological condition. Titration experiments have revealed that the binding ability of levofloxacin toward Al3+ is much stronger than that of ciprofloxacin and lomefloxacin at pD 2.5. In contrast to the complexation with Al3+, the binding of these drugs with other metal ions such as Ca2+ and Mg2+ is much weaker; NMR signals have shown no appreciable downfield shift by the addition of Ca2+ and Mg2+. Based on these results, it is concluded that the fluoroquinolone antimicrobials examined in the present study at pD 2.5 exist as stable complexes in the presence of Al3+ and the absorptivity of the drugs on oral administration could be affected by Al3+. Copyright (C) 1999 Elsevier Science B.V.
KW - C-NMR
KW - Complexation
KW - H-NMR
KW - Metal ions
KW - Quinolone antimicrobials
UR - http://www.scopus.com/inward/record.url?scp=0032920849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032920849&partnerID=8YFLogxK
U2 - 10.1016/S0731-7085(98)00233-7
DO - 10.1016/S0731-7085(98)00233-7
M3 - Article
C2 - 9925342
AN - SCOPUS:0032920849
SN - 0731-7085
VL - 18
SP - 1057
EP - 1067
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
IS - 6
ER -